Aytu BioPharma Inc. Revenue 2014–2025
Aytu BioPharma Inc. annual/quarterly revenue history and growth rate from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aytu BioPharma Inc. revenue for the quarter ending March 31, 2026 was 12.4 M, a 32.74% decrease year-over-year.
- Aytu BioPharma Inc. revenue for the twelve months ending March 31, 2026 was 59.9 M, a 8.62% decrease year-over-year.
- Aytu BioPharma Inc. annual revenue for 2025 was 66.4 M, a 1.84% increase from 2024.
- Aytu BioPharma Inc. annual revenue for 2024 was 65.2 M, a 39.31% decrease from 2023.
- Aytu BioPharma Inc. annual revenue for 2023 was 107.4 M, a 11.10% increase from 2022.
- Aytu BioPharma Inc. annual revenue for 2022 was 96.7 M.
Aytu BioPharma Inc. (AYTU) — Frequently Asked Questions
Aytu BioPharma Inc. (AYTU) is a publicly traded US company. It has a market capitalization of $20M. In fiscal 2025 it reported revenue of $66M and net income of -$14M. Explore AYTU's stock price, financial statements, earnings history, margins and key ratios below.
What is Aytu BioPharma Inc.'s market cap?
Aytu BioPharma Inc. (AYTU) has a market capitalization of $20M.
What is the AYTU stock price?
AYTU trades at $2.18 (-2.68% on the day).
How much revenue does Aytu BioPharma Inc. make?
Aytu BioPharma Inc. reported revenue of $66M in fiscal 2025.
Is AYTU profitable?
In fiscal 2025, Aytu BioPharma Inc. reported net income of -$14M.